ROLE OF THE COMPLEMENT AND CYTOKINES IN THE EARLYDIAGNOSIS OF MULTIPLE SCLEROSIS



如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

In the article are presented the results of the study of blood and cerebrospinal fluid for cytokines and the complement proteins in 22 patients with clinically isolated syndrome in accordance with the subsequent development of the disease. It is find out the differences between the concentration of some complement proteins in patients with the developed during the observation the definite multiple scle- rosis in comparison with the patients with clinically isolated syndrome, and cytokine status. The de- termination of immunological predictors of multiple sclerosis development may help to understand the dynamics of pathological process and to start the early treatment.

全文:

受限制的访问

作者简介

S Lobzin

North-West State Medical university named after I.I. Mechnikov

N Serebryanaya

North-West State Medical university named after I.I. Mechnikov

A Ischenko

North-West State Medical university named after I.I. Mechnikov

V Golovkin

North-West State Medical university named after I.I. Mechnikov

M Fomintseva

North-West State Medical university named after I.I. Mechnikov

I Kula

North-West State Medical university named after I.I. Mechnikov

参考

  1. Завалишин И.А., Головкин В.И. Рассеянный склероз. Избранные вопросы теории и практик. - М.: МИА, 2000. - 639 с.
  2. Завалишин И.А., Переседова А.В., Стойда Н.И., Гурьянова О.Е., Арзуманян Н.Ш., Алексеева Н.С., Елисеева Д.Д., Гулевская Т.С., Брюхов В.В. Диагностика и лечение рассеянного склероза// Журнал неврологии и психиатрии. - 2011. - № 6. - С. 89-96.
  3. Bielekova, B. Development of biomarkers in multiple sclerosis / B.Bielekova, R.Martin. // Brain. - 2004. - Vol.127. - N.7. - P.1463-1478.
  4. Bitsch, A. Tumour necrosis factor α mRNA expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology / A. Bitsch, T. Kuhlmann, C. Da Costa, et al. // Glia. - 2000. - Vol.29. - N.4. - P. 366-375.
  5. Boos, L. Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis. L.Boos, I.L.Campbell, R.Ames, R.A. Wetsel, S.R. Barnum. // J. Immunol. - 2004. - Vol.173. - N.7. - P.4708-4714.
  6. Huang, W.X. Cytokine analysis in multiple sclerosis by competitive RT-PCR: a decreased expression of IL-10 and an increased expression of TNF-α in chronic progression / W.X.Huang, P. Huang, H. Link, J. Hillert // Mult. Scler. - 1999. - Vol.5. - N.5. - P. 342-348.
  7. Navikas, V. Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis / V. Navikas, J.Link , W.Palasik, M.Soderstrom, et al. // Scand. J. Immunol. - 1995. - Vol.41. - N.2. - P. 171-178.
  8. Ozenci, V. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-α (TNF-α)- and IL-10-secreting blood cells that is corrected by interferon-β (IFN-β) treatment / V. Ozenci, M. Kouwenhoven, Y.M. Huang, et al. // Clin. Exp. Immunol. - 2000. - Vol.120. - N.1. - P. 147-153.
  9. Polman, C.H. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald Criteria. / C.H. Polman, S.C. Reingold, B. Banwell, et. al.// Ann Neurol. - 2011. - Vol.69. - N.2. - P. 292-302.
  10. Scolding, N.J. Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies / N.J. Scolding, B.P. Morgan, A. Houston, et al. // J. Neurol. Sci. - 1989. - Vol.89. - N.2-3. - P. 289-300.
  11. Sospedra, M. Immunology of Multiple sclerosis. / M. Sospedra, R. Martin // Annu. Rev. Immunol. - 2005. - Vol. 23. - P. 683-747.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Lobzin S.V., Serebryanaya N.B., Ischenko A.M., Golovkin V.I., Fomintseva M.V., Kula I.I., 2015

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 71733 от 08.12.2017.